ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 168 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2020. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,332,000 | -78.0% | 110,558 | -61.4% | 0.06% | -77.0% |
| Q2 2021 | $6,052,000 | +25.1% | 286,170 | +65.9% | 0.28% | -4.4% |
| Q1 2021 | $4,838,000 | +1.2% | 172,463 | -6.2% | 0.30% | -24.1% |
| Q4 2020 | $4,779,000 | -9.6% | 183,824 | +29.2% | 0.39% | -15.9% |
| Q3 2020 | $5,288,000 | +8.6% | 142,264 | +49.9% | 0.46% | -17.0% |
| Q2 2020 | $4,870,000 | +623.6% | 94,907 | +344.5% | 0.56% | +272.7% |
| Q1 2020 | $673,000 | – | 21,351 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 2,818,835 | $59,618,000 | 21.09% |
| Bellevue Group AG | 4,519,164 | $95,580,000 | 0.93% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,713,176 | $36,234,000 | 0.84% |
| Rhenman & Partners Asset Management AB | 572,267 | $12,103,000 | 0.82% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 64,434 | $1,363,000 | 0.45% |
| Boxer Capital, LLC | 500,000 | $10,575,000 | 0.37% |
| EMC Capital Management | 27,566 | $583,000 | 0.33% |
| WASATCH ADVISORS LP | 3,766,935 | $79,671,000 | 0.32% |
| Avidity Partners Management LP | 400,000 | $8,460,000 | 0.23% |
| Cinctive Capital Management LP | 186,170 | $3,937,000 | 0.18% |